L.S. Hofstra

675 total citations
10 papers, 500 citations indexed

About

L.S. Hofstra is a scholar working on Surgery, Reproductive Medicine and Oncology. According to data from OpenAlex, L.S. Hofstra has authored 10 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Reproductive Medicine and 3 papers in Oncology. Recurrent topics in L.S. Hofstra's work include Ovarian cancer diagnosis and treatment (5 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and Testicular diseases and treatments (2 papers). L.S. Hofstra is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and Testicular diseases and treatments (2 papers). L.S. Hofstra collaborates with scholars based in Netherlands. L.S. Hofstra's co-authors include Harry J.G.M. Crijns, A. Bertrand, P. A. Doevendans, León J. De Windt, Elisabeth G.E. de Vries, Nanno H. Mulder, P.H.B. Willemse, N. H. Mulder, Pax H.B. Willemse and Μ. Borgers and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Cardiovascular Research.

In The Last Decade

L.S. Hofstra

10 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L.S. Hofstra Netherlands	9	205	138	102	74	72	10	500
Kai Hu Germany	12	253 1.2×	238 1.7×	57 0.6×	34 0.5×	51 0.7×	16	615
Irène Papageorgiou Switzerland	16	307 1.5×	235 1.7×	86 0.8×	19 0.3×	43 0.6×	24	548
Francisco R. González‐Pacheco Spain	12	283 1.4×	235 1.7×	61 0.6×	12 0.2×	66 0.9×	16	711
M. Ahsan Siraj Canada	9	149 0.7×	51 0.4×	56 0.5×	62 0.8×	47 0.7×	12	411
Takuya Hattori Japan	16	215 1.0×	202 1.5×	159 1.6×	8 0.1×	117 1.6×	41	744
Hongbin Liu China	19	442 2.2×	80 0.6×	160 1.6×	93 1.3×	129 1.8×	43	962
Zhanhui Du China	9	210 1.0×	55 0.4×	56 0.5×	21 0.3×	91 1.3×	28	418
Byung‐Hyun Park South Korea	14	206 1.0×	42 0.3×	114 1.1×	9 0.1×	70 1.0×	15	531

Countries citing papers authored by L.S. Hofstra

Since Specialization

Citations

This map shows the geographic impact of L.S. Hofstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.S. Hofstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.S. Hofstra more than expected).

Fields of papers citing papers by L.S. Hofstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.S. Hofstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.S. Hofstra. The network helps show where L.S. Hofstra may publish in the future.

Co-authorship network of co-authors of L.S. Hofstra

This figure shows the co-authorship network connecting the top 25 collaborators of L.S. Hofstra. A scholar is included among the top collaborators of L.S. Hofstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.S. Hofstra. L.S. Hofstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bertrand, A., et al.. (2005). Myocyte apoptosis in heart failure. Cardiovascular Research. 67(1). 21–29. 298 indexed citations

Driesen, Ronald B., G Dispersyn, Fons Verheyen, et al.. (2005). Partial cell fusion: A newly recognized type of communication between dedifferentiating cardiomyocytes and fibroblasts. Cardiovascular Research. 68(1). 37–46. 44 indexed citations

Zijlstra, Jan G., et al.. (2005). Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.. PubMed. 63(8). 316–8. 11 indexed citations

Hofstra, L.S., Elisabeth G.E. de Vries, A.G.J. van der Zee, et al.. (2002). Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer. Gynecologic Oncology. 85(3). 517–523. 18 indexed citations

Hofstra, L.S., Elisabeth G.E. de Vries, A.G.J. van der Zee, et al.. (2001). A phase I and pharmacokinetic study of intraperitoneal topotecan. British Journal of Cancer. 85(11). 1627–1633. 22 indexed citations

Hofstra, L.S., Elisabeth G.E. de Vries, Nanno H. Mulder, & P.H.B. Willemse. (2000). Intraperitoneal chemotherapy in ovarian cancer. Cancer Treatment Reviews. 26(2). 133–143. 31 indexed citations

Hofstra, L.S., et al.. (2000). Combined treatment with goserelin and tamoxifen in patients with advanced chemotherapy resistant ovarian cancer.. PubMed. 19(4C). 3627–30. 13 indexed citations

Wymenga, A.N.M., L.S. Hofstra, F. K. L. Spijkervet, et al.. (1999). Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.. PubMed. 5(6). 1363–8. 43 indexed citations

Hofstra, L.S., Gunnar B. Kristensen, P.H.B. Willemse, et al.. (1998). Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.. Journal of Clinical Oncology. 16(10). 3335–3344. 5 indexed citations

10.

Jong, Robert S. de, L.S. Hofstra, Pax H.B. Willemse, et al.. (1997). Effect of Low-Dose Oral Etoposide on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer. Gynecologic Oncology. 66(2). 197–201. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact